A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis von Tayek, John A., Stolz, Andrew A., Nguyen, Danh V., Fleischman, M. Wayne, Donovan, John A., Alcorn, Joseph M., Chao, Daniel C-K., Asghar, Aliya, Morgan, Timothy R., Birudaraju, Divya, Botwin, Greg, Buddha, Hema, Cherukuri, Lavanya, Cruz, Sheena, French, Monique, Gonzalez, Rachel, Gozum, Jessica, Gutierrez, Rebecca, Hamal, Sajad, Head, Preston, Jones, Carol, Kaplowitz, Neil, Lee, Robert, MacHarg, Lauren, Milstein, Susan, Ouyang, Yuxin, Rico, Christy, Zarick, Cory

Volltext